Who Paid My Doc
Sowmya Kurtakoti
Geriatric Medicine Hartford, CT Medical Doctor
NPI 1336329465 CMS profile 657673
1229 Albany Ave, Hartford, CT 06112
General payments
$8,635
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Sowmya Kurtakoti of Hartford, CT is reported in the CMS Open Payments database as having received $8,635 across 6 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 95th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $8,635 | 6 |
Beside peers
- Sowmya Kurtakoti
- Geriatric Medicine median
- Middle half of Geriatric Medicine
- National median
In program year 2025, general payments to Sowmya Kurtakoti were reported at $8,635. Among 512 Geriatric Medicine profiles paid that year, the median was $120 and the middle half received between $37 and $350.
Show as a table
| Year | Sowmya Kurtakoti | Geriatric Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $96 | $28–$339 | $163 |
| 2020 | $0 | $99 | $28–$262 | $114 |
| 2021 | $0 | $94 | $27–$318 | $132 |
| 2022 | $0 | $103 | $34–$338 | $149 |
| 2023 | $0 | $109 | $39–$320 | $160 |
| 2024 | $0 | $125 | $36–$371 | $164 |
| 2025 | $8,635 | $120 | $37–$350 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 145 drugsPart D claims
9,732
Drug cost
$642,137
Branded share of claims
15.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 328 | $198,941 | |
| Xarelto Rivaroxaban | Brand | 66 | $44,686 | |
| Januvia Sitagliptin Phosphate | Brand | 25 | $32,126 | |
| Trulicity Dulaglutide | Brand | 30 | $31,550 | |
| Jardiance Empagliflozin | Brand | 40 | $30,881 | |
| Ozempic Semaglutide | Brand | 23 | $27,214 | |
| Tradjenta Linagliptin | Brand | 46 | $20,494 | |
| Gemtesa Vibegron | Brand | 36 | $16,599 | |
| Spiriva Respimat Tiotropium Bromide | Brand | 11 | $15,117 | |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | Brand | 21 | $13,604 |
The 10 drugs with the highest cost, of 145 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 38 billing codesPaid by Medicare
$85,806
Medicare patients
333
Services billed
2,680
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 54% | |
| Depression | 32% | |
| Osteoporosis | 30% | |
| Chronic kidney disease | 29% | |
| Alzheimer's or dementia | 29% | |
| Ischemic heart disease | 27% | |
| Atrial fibrillation | 27% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Vaccine for influenza for injection into muscle 90662 | Office | 54 | 54 | $4,369 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Geriatric Medicine in Connecticut
Related records
Geriatric Medicine in Connecticut
Practitioners in the same specialty and state, ranked by reported value.
All Geriatric Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Connecticut
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.